Awiqli® (insulin icodec) injection, if approved, has the potential to be the first once-weekly basal insulin treatment available in the

The DNA synthesis inhibitors market is projected to witness substantial growth in the coming years, driven by the rising incidence

Phase III trial presented at ASTRO in San Francisco finds five-treatment regimen poised to become new standard of care. SAN

Funding to Launch new CPG Sustainable Consumer Brand FORT LAUDERDALE, Fla., Sept. 29, 2025 /PRNewswire/ -- Aspyr Living, a natural

NEW ORLEANS, LA, UNITED STATES, September 29, 2025 /⁨EINPresswire.com⁩/ -- Gasology today announced the launch of Gasology Dispatch, a transformative

Asia-Pacific held the largest share in 2021, contributing nearly two-fifths of global revenue, and is projected to grow at a